The incidence of Type 2 diabetes in youth is rising at an alarming rate, presenting a distinct and aggressive clinical challenge compared to the adult-onset form. The 2018 Clinical Practice Guidelines highlight that adolescents with Type 2 diabetes face a more rapid decline in beta-cell function and a higher risk of early complications, necessitating prompt diagnosis and intensive management.
This practice exam tests your ability to identify at-risk youth, apply specific screening algorithms, and implement appropriate pharmacologic and lifestyle interventions.
Key Concepts Covered in This Exam:
Targeted Screening: Identifying the specific criteria for screening (e.g., age 8 with 3 risk factors or post-puberty with 2 risk factors) and the recommended interval of every 2 years.
Diagnostic Differentiation: Understanding how to distinguish Type 2 diabetes from Type 1 diabetes and monogenic diabetes in the pediatric population.
Pharmacotherapy: Identifying metformin as the first-line medication in combination with lifestyle intervention, and knowing when the addition of insulin is mandatory (e.g., severe metabolic decompensation or ketosis).
Comorbidity Management: Recognizing the high prevalence of associated conditions such as Polycystic Ovary Syndrome (PCOS), Nonalcoholic Fatty Liver Disease (NAFLD), and dyslipidemia.
Psychosocial Care: Acknowledging the critical need for mental health support, as youth with Type 2 diabetes have higher rates of depression and distress compared to their peers.
